Glioblastoma in the Crosshairs: Development of a Dual Reporter Assay for Discovery of Olig2 Inhibiting Drugs

Description
A coincidence reporter construct, consisting of the p21-promoter and two luciferase genes (Firefly and Renilla), was constructed for the screening of drugs that might inhibit Olig2's tumorigenic role in glioblastoma. The reporter construct was tested using an Olig2 inhibitor, HSP990,

A coincidence reporter construct, consisting of the p21-promoter and two luciferase genes (Firefly and Renilla), was constructed for the screening of drugs that might inhibit Olig2's tumorigenic role in glioblastoma. The reporter construct was tested using an Olig2 inhibitor, HSP990, as well as short hairpin RNA targeting Olig2. Further confirmatory analysis is needed before the reporter cell line is ready for high-throughput screening at the NIH and lead compound selection.

Downloads

One or more components are restricted to ASU affiliates. Please sign in to view the rest.
Restrictions Statement

Barrett Honors College theses and creative projects are restricted to ASU community members.

Details

Contributors
Date Created
2014-05
Resource Type
Language
  • eng
Additional Information
English
Series
  • Academic Year 2013-2014
Extent
  • 18 pages